Last reviewed · How we verify

Bepotastine besilate-fluticasone propionate

Bausch & Lomb Incorporated · Phase 2 active Small molecule

Bepotastine besilate-fluticasone propionate is a Antihistamine and corticosteroid combination Small molecule drug developed by Bausch & Lomb Incorporated. It is currently in Phase 2 development for Allergic conjunctivitis.

Histamine H1 receptor antagonist and corticosteroid combination

Histamine H1 receptor antagonist and corticosteroid combination Used for Allergic conjunctivitis.

At a glance

Generic nameBepotastine besilate-fluticasone propionate
SponsorBausch & Lomb Incorporated
Drug classAntihistamine and corticosteroid combination
TargetHistamine H1 receptor
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 2

Mechanism of action

Bepotastine besilate is a histamine H1 receptor antagonist and fluticasone propionate is a corticosteroid. This combination is used to treat allergic conjunctivitis.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bepotastine besilate-fluticasone propionate

What is Bepotastine besilate-fluticasone propionate?

Bepotastine besilate-fluticasone propionate is a Antihistamine and corticosteroid combination drug developed by Bausch & Lomb Incorporated, indicated for Allergic conjunctivitis.

How does Bepotastine besilate-fluticasone propionate work?

Histamine H1 receptor antagonist and corticosteroid combination

What is Bepotastine besilate-fluticasone propionate used for?

Bepotastine besilate-fluticasone propionate is indicated for Allergic conjunctivitis.

Who makes Bepotastine besilate-fluticasone propionate?

Bepotastine besilate-fluticasone propionate is developed by Bausch & Lomb Incorporated (see full Bausch & Lomb Incorporated pipeline at /company/bausch-lomb-incorporated).

What drug class is Bepotastine besilate-fluticasone propionate in?

Bepotastine besilate-fluticasone propionate belongs to the Antihistamine and corticosteroid combination class. See all Antihistamine and corticosteroid combination drugs at /class/antihistamine-and-corticosteroid-combination.

What development phase is Bepotastine besilate-fluticasone propionate in?

Bepotastine besilate-fluticasone propionate is in Phase 2.

What are the side effects of Bepotastine besilate-fluticasone propionate?

Common side effects of Bepotastine besilate-fluticasone propionate include Eye pruritus, Eye irritation, Headache.

What does Bepotastine besilate-fluticasone propionate target?

Bepotastine besilate-fluticasone propionate targets Histamine H1 receptor and is a Antihistamine and corticosteroid combination.

Related